All Clinical Trials
View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYTwo Step Haplo With Radiation Conditioning
RADIATION-BASED REDUCED INTENSITY CONDITIONINGMaster Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials
MYELOMATCH MASTER PROTOCOLPhase II Clinical Trial of 2 Step ATG Combined With Tacrolimus and Mini Methotrexate for Prevention of Acut...
ATG DOSING FOR GVHD PREVENTIONPhase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vers...
MELPHALAN WITH OR WITHOUT SILTUXIMABPhase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood ...
A/B TCD PERIPHERAL BLOOD STEM CELL TRANSPLANTATIONPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMABPhase I Study of Escalating Doses of Total Marrow and Lymphoid Irradiation (TMLI) Combined With Fludarabine...
TOTAL MARROW AND LYMPHOID IRRADIATIONA Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoi...
IS-FREE TREG STEM CELL TRANSPLANTPhase I Study of Escalating Doses of 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody Added to the Cond...
RADIATION-BASED DARATUMUMABHigh Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
HIGH DOSE ASCORBIC ACID W/ MELPHALANUmbilical Cord Blood Transplantation From Unrelated Donors
UMBILICAL CORD BLOOD TRANSPLANTATIONA Phase I Study of Intensity Modulated Total Marrow Irradiation (IMTMI) in Addition to Fludarabine/Melphala...
INTENSITY MODULATED TOTAL MARROW IRRADIATIONPeri-Hematopoietic Cell Transplantation Ruxolitinib in Patients With Myelofibrosis and Myelodysplastic Synd...
RUXOLITINIB DURING STEM CELL TRANSPLANT
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vers...
MELPHALAN WITH OR WITHOUT SILTUXIMABPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMAB
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYPhase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vers...
MELPHALAN WITH OR WITHOUT SILTUXIMAB
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYHigh Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
HIGH DOSE ASCORBIC ACID W/ MELPHALAN
Smoldering Myeloma
The following is a listing of clinical trials for patients with Smoldering Myeloma.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials